Small cell lymphoma: Difference between revisions
Tarek Nafee (talk | contribs) |
(Mahshid) |
||
| (8 intermediate revisions by one other user not shown) | |||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
'''Small cell lymphoma''' (also known as SLL) is a type of mature B-cell chronic lymphocytic leukemia that presents primarily in the lymph nodes. | '''Small cell lymphoma''' (also known as SLL) is a type of mature B-cell [[chronic lymphocytic leukemia]] that presents primarily in the lymph nodes. In 1924, small cell lymphoma was first discovered by the American physician Dr. George Minot.<ref name="pmid8038488">{{cite journal| author=Rai KR| title=Progress in chronic lymphocytic leukaemia: a historical perspective. | journal=Baillieres Clin Haematol | year= 1993 | volume= 6 | issue= 4 | pages= 757-65 | pmid=8038488 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8038488 }} </ref> There is no standardized classification system for small cell lymphoma. The pathogenesis of small cell lymphoma is characterized by the malignant infiltration of lymphocytic cells into the [[bone marrow]] where they interfere with the production of other [[hematopoeitic]] cell lines such as [[red blood cell]]s and [[platelet]]s. Small cell lymphoma arises from pre-follicular center [[B cell]]s that are normally involved in the process of human [[immunoglobulin]]s production. Small cell lymphoma represents 90 % of all B-cell [[chronic lymphocytic leukemia]]s in the United States. Small cell lymphoma presents at a median age of 65 years. Males are slightly more affected with small cell lymphoma than females. Symptoms of small cell lymphoma may include [[fever]],[[weight loss]], generalized [[weakness]], [[anorexia]], and [[night sweats]]. The mainstay therapy of small cell lymphoma is [[chemotherapy]] and [[radiotherapy]]. | ||
[[weight loss]], generalized [[weakness]], anorexia, and | |||
==Historical Perspective== | ==Historical Perspective== | ||
In 1924, small cell lymphoma was first discovered by the American physician Dr. George Minot.<ref name="pmid8038488">{{cite journal| author=Rai KR| title=Progress in chronic lymphocytic leukaemia: a historical perspective. | journal=Baillieres Clin Haematol | year= 1993 | volume= 6 | issue= 4 | pages= 757-65 | pmid=8038488 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8038488 }} </ref> | |||
==Classification== | ==Classification== | ||
There is no classification system for small cell lymphoma.<ref name=WHO>World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, Swerdlow SH, Campo E, Harris NL (Eds), IARC Press, Lyon 2008.</ref> Small cell lymphoma is a subtype of of B-cell chronic lymphocytic leukemia. | There is no classification system for small cell lymphoma.<ref name=WHO>World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, Swerdlow SH, Campo E, Harris NL (Eds), IARC Press, Lyon 2008.</ref> Small cell lymphoma is a subtype of of B-cell [[chronic lymphocytic leukemia]]. | ||
==Pathophysiology== | ==Pathophysiology== | ||
===Pathogenesis=== | ===Pathogenesis=== | ||
| Line 51: | Line 51: | ||
The prevalence of small cell lymphoma is low. Small cell lymphoma represents 90 % of all B-cell [[chronic lymphocytic leukemia]]s in the United States.<ref name="pmid22693682">{{cite journal |vauthors=Schwock J, Geddie WR |title=Diagnosis of B-cell non-hodgkin lymphomas with small-/intermediate-sized cells in cytopathology |journal=Patholog Res Int |volume=2012 |issue= |pages=164934 |year=2012 |pmid=22693682 |pmc=3368210 |doi=10.1155/2012/164934 |url=}}</ref> | The prevalence of small cell lymphoma is low. Small cell lymphoma represents 90 % of all B-cell [[chronic lymphocytic leukemia]]s in the United States.<ref name="pmid22693682">{{cite journal |vauthors=Schwock J, Geddie WR |title=Diagnosis of B-cell non-hodgkin lymphomas with small-/intermediate-sized cells in cytopathology |journal=Patholog Res Int |volume=2012 |issue= |pages=164934 |year=2012 |pmid=22693682 |pmc=3368210 |doi=10.1155/2012/164934 |url=}}</ref> | ||
===Age=== | ===Age=== | ||
The median age at diagnosis is 65 years | The median age at diagnosis is 65 years. | ||
===Gender=== | ===Gender=== | ||
Males are more commonly affected with small cell lymphoma than females. | Males are more commonly affected with small cell lymphoma than females. | ||
| Line 58: | Line 58: | ||
==Risk Factors== | ==Risk Factors== | ||
The risk factors for the development of small cell lymphoma are not well established. The most consistent risk factor is a family history of [[non-hodgkins lymphoma]].<ref name="pmid25174025">{{cite journal| author=Slager SL, Benavente Y, Blair A, Vermeulen R, Cerhan JR, Costantini AS et al.| title=Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. | journal=J Natl Cancer Inst Monogr | year= 2014 | volume= 2014 | issue= 48 | pages= 41-51 | pmid=25174025 | doi=10.1093/jncimonographs/lgu001 | pmc=4155456 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25174025 }} </ref> | |||
== Natural History, Complications and Prognosis== | == Natural History, Complications and Prognosis== | ||
===Natural History=== | ===Natural History=== | ||
| Line 68: | Line 64: | ||
===Complications=== | ===Complications=== | ||
Common complications of small cell lymphoma include:<ref name="pmid22693682">{{cite journal |vauthors=Schwock J, Geddie WR |title=Diagnosis of B-cell non-hodgkin lymphomas with small-/intermediate-sized cells in cytopathology |journal=Patholog Res Int |volume=2012 |issue= |pages=164934 |year=2012 |pmid=22693682 |pmc=3368210 |doi=10.1155/2012/164934 |url=}}</ref> | Common complications of small cell lymphoma include:<ref name="pmid22693682">{{cite journal |vauthors=Schwock J, Geddie WR |title=Diagnosis of B-cell non-hodgkin lymphomas with small-/intermediate-sized cells in cytopathology |journal=Patholog Res Int |volume=2012 |issue= |pages=164934 |year=2012 |pmid=22693682 |pmc=3368210 |doi=10.1155/2012/164934 |url=}}</ref> | ||
*Severe immunodeficiency | *Severe [[immunodeficiency]] | ||
*Warm [[autoimmune hemolytic anemia]] | *Warm [[autoimmune hemolytic anemia]] | ||
*Richter's transformation | *[[Richter's transformation]] | ||
===Prognosis=== | ===Prognosis=== | ||
The prognosis of small cell lymphoma is generally poor; the 5-year survival rate of patients with small cell lymphoma is approximately 51-67%.<ref name="pmid22693682">{{cite journal |vauthors=Schwock J, Geddie WR |title=Diagnosis of B-cell non-hodgkin lymphomas with small-/intermediate-sized cells in cytopathology |journal=Patholog Res Int |volume=2012 |issue= |pages=164934 |year=2012 |pmid=22693682 |pmc=3368210 |doi=10.1155/2012/164934 |url=}}</ref> | |||
== Diagnosis == | == Diagnosis == | ||
| Line 105: | Line 101: | ||
== Treatment == | == Treatment == | ||
=== Medical Therapy === | === Medical Therapy === | ||
The mainstay of therapy for small cell lymphoma is chemotherapy and radiotherapy. | |||
=== Surgery === | === Surgery === | ||
Surgery is not recommended among patients with small cell lymphoma.<ref name="pmid22693682">{{cite journal |vauthors=Schwock J, Geddie WR |title=Diagnosis of B-cell non-hodgkin lymphomas with small-/intermediate-sized cells in cytopathology |journal=Patholog Res Int |volume=2012 |issue= |pages=164934 |year=2012 |pmid=22693682 |pmc=3368210 |doi=10.1155/2012/164934 |url=}}</ref> | |||
*The diagnosis of small cell lymphoma is made with a excisional lymph node biopsy combined with a bone marrow biopsy. | *The diagnosis of small cell lymphoma is made with a excisional lymph node biopsy combined with a bone marrow biopsy. | ||
=== Prevention === | === Prevention === | ||
====Primary Prevention==== | |||
There are no primary preventive measures available for small cell lymphoma. | |||
====Secondary Prevention==== | |||
Secondary prevention strategies following small cell lymphoma include follow up every 6 to 12 months. Follow-up testing includes a [[complete blood count]] and [[physical examination]]. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category: Oncology]] | [[Category:Oncology]] | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
Latest revision as of 02:16, 6 November 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Synonyms and keywords: Small cell lymphocytic leukemia; SLL
Overview
Small cell lymphoma (also known as SLL) is a type of mature B-cell chronic lymphocytic leukemia that presents primarily in the lymph nodes. In 1924, small cell lymphoma was first discovered by the American physician Dr. George Minot.[1] There is no standardized classification system for small cell lymphoma. The pathogenesis of small cell lymphoma is characterized by the malignant infiltration of lymphocytic cells into the bone marrow where they interfere with the production of other hematopoeitic cell lines such as red blood cells and platelets. Small cell lymphoma arises from pre-follicular center B cells that are normally involved in the process of human immunoglobulins production. Small cell lymphoma represents 90 % of all B-cell chronic lymphocytic leukemias in the United States. Small cell lymphoma presents at a median age of 65 years. Males are slightly more affected with small cell lymphoma than females. Symptoms of small cell lymphoma may include fever,weight loss, generalized weakness, anorexia, and night sweats. The mainstay therapy of small cell lymphoma is chemotherapy and radiotherapy.
Historical Perspective
In 1924, small cell lymphoma was first discovered by the American physician Dr. George Minot.[1]
Classification
There is no classification system for small cell lymphoma.[2] Small cell lymphoma is a subtype of of B-cell chronic lymphocytic leukemia.
Pathophysiology
Pathogenesis
- The pathogenesis of small cell lymphoma is characterized by the malignant infiltration of lymphocytic cells into the bone marrow, where they interfere with the production of red blood cells and platelets.
- Small cell lymphoma arises from pre-follicular center B cells that are normally involved in the process of human immunoglobulins production.
Genetics
Genes involved in the development of small cell lymphoma include:
- Chromosome 11 long arm deletion
- Chromosome 13 long arm deletion (most common genetic mutation)
- Chromosome 17 short arm deletion
- Trisomy 12
Gross Pathology
There are no remarkable gross pathological findings in small cell lymphoma.
Microscopic Pathology
On microscopic histopathological analysis, characteristic findings of small cell lymphoma include:
- Small lymphoid cells
- Thin cytoplasmic border
- Dense nucleus
- Lack of nucleolus
- Clumped chromatin aggregates
- The presence of smudge cells
- The presence of gumprecht nuclear shadows
On immunohistopathological analysis, characteristic findings of small cell lymphoma may include:
Causes
There are no established causes for small cell lymphoma.
Differentiating Small Cell Lymphoma from Other Diseases
Small cell lymphoma must be differentiated from other diseases that cause fever, anorexia, and weakness such as:[3]
Epidemiology and Demographics
Prevalence
The prevalence of small cell lymphoma is low. Small cell lymphoma represents 90 % of all B-cell chronic lymphocytic leukemias in the United States.[3]
Age
The median age at diagnosis is 65 years.
Gender
Males are more commonly affected with small cell lymphoma than females.
Race
There is no racial predilection for small cell lymphoma.
Risk Factors
The risk factors for the development of small cell lymphoma are not well established. The most consistent risk factor is a family history of non-hodgkins lymphoma.[4]
Natural History, Complications and Prognosis
Natural History
The majority of patients with small cell lymphoma are symptomatic. Early clinical features include generalized weakness, anorexia, and night sweats. If left untreated, patients with small cell lymphoma may progress to develop recurrent infections.
Complications
Common complications of small cell lymphoma include:[3]
Prognosis
The prognosis of small cell lymphoma is generally poor; the 5-year survival rate of patients with small cell lymphoma is approximately 51-67%.[3]
Diagnosis
Symptoms
Symptoms of small cell lymphoma may include the following:
- Fever
- Weight loss
- Muscle wasting
- Generalized weakness
- Anorexia
- Night sweats
Physical Examination
Patients with small cell lymphoma often appear pale and malnourished. Physical examination may be remarkable for:
- Pallor
- Petechiae
- Leukemia cutis (infiltration of neoplastic leukocytes or their precursors into the skin resulting in clinically identifiable cutaneous lesions)
- Enlarged and palpable cervical lymph nodes
- Dacryoadenitis
Laboratory Findings
Laboratory findings consistent with the diagnosis of small cell lymphoma include:[5]
- Absolute lymphocytosis (>5000 cells/μl)[6][7]
- Decreased hemoglobin concentration
- Decreased platelets count
Imaging Findings
There are no specific imaging findings associated with small cell lymphoma. CT scan may be helpful in the diagnosis small cell lymphoma, findings may include enlarged lymph nodes (>2 cm).
Treatment
Medical Therapy
The mainstay of therapy for small cell lymphoma is chemotherapy and radiotherapy.
Surgery
Surgery is not recommended among patients with small cell lymphoma.[3]
- The diagnosis of small cell lymphoma is made with a excisional lymph node biopsy combined with a bone marrow biopsy.
Prevention
Primary Prevention
There are no primary preventive measures available for small cell lymphoma.
Secondary Prevention
Secondary prevention strategies following small cell lymphoma include follow up every 6 to 12 months. Follow-up testing includes a complete blood count and physical examination.
References
- ↑ 1.0 1.1 Rai KR (1993). "Progress in chronic lymphocytic leukaemia: a historical perspective". Baillieres Clin Haematol. 6 (4): 757–65. PMID 8038488.
- ↑ World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, Swerdlow SH, Campo E, Harris NL (Eds), IARC Press, Lyon 2008.
- ↑ 3.0 3.1 3.2 3.3 3.4 Schwock J, Geddie WR (2012). "Diagnosis of B-cell non-hodgkin lymphomas with small-/intermediate-sized cells in cytopathology". Patholog Res Int. 2012: 164934. doi:10.1155/2012/164934. PMC 3368210. PMID 22693682.
- ↑ Slager SL, Benavente Y, Blair A, Vermeulen R, Cerhan JR, Costantini AS; et al. (2014). "Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project". J Natl Cancer Inst Monogr. 2014 (48): 41–51. doi:10.1093/jncimonographs/lgu001. PMC 4155456. PMID 25174025.
- ↑ Review Article: Diagnostic Workup of Small B Cell Lymphomas: A Laboratory Perspective http://www.hindawi.com/journals/lymph/2012/346084/A Accessed on May 4, 2016
- ↑ Nabhan C, Rosen ST (2014). "Chronic lymphocytic leukemia: a clinical review". JAMA. 312 (21): 2265–76. doi:10.1001/jama.2014.14553. PMID 25461996.
- ↑ Chronic Lymphocytic Leukemia. Wikipedia (2015) https://en.wikipedia.org/wiki/B-cell_chronic_lymphocytic_leukemia Accessed on October,12 2015